Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Qliro - NCI miss, but TPV growth still healthy

20 juli 2026

<a id="bm-comp-b3e1344b-8476-4c40-be09-b0802bf1ea43" name="bm-comp-b3e1344b-8476-4c40-be09-b0802bf1ea43" class="BMCustomAnchor"></a><table><tr><td bm-component-id="b3e1344b-8476-4c40-be09-b0802bf1ea43" style="vertical-align: top; width:100.000000%;"><ul><li>Net commission income miss</li><li>Negative TPV revisions result in lower earnings</li><li>Merchant base still growing, supporting growth</li></ul></td></tr></table><a id="bm-comp-f6b0bb79-fdb9-4cf7-bdfc-2a57f0dc010f" name="bm-comp-f6b0bb79-fdb9-4cf7-bdfc-2a57f0dc010f" class="BMCustomAnchor"></a><table><tr><td bm-component-id="f6b0bb79-fdb9-4cf7-bdfc-2a57f0dc010f" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Net commission income miss</h3><p>Qliro reported a 91% operating profit miss versus FactSet consensus and a 92% miss versus ABGSCe, mainly driven by weaker-than-expected net commission income (SEK 16.7m vs. ABGSCe SEK 23.2m and consensus SEK 21.5m) despite TPV growing 28.1% y-o-y. BNPL volumes grew faster than expected (46.7% vs. ABGSCe 41.3%), supporting stronger net interest income (SEK 104.5m vs. ABGSCe 102.9m). Credit losses were also better than expected at SEK -23.7m (vs. ABGSCe SEK -27.0m and consensus SEK -29.5m), suggesting investments in the new credit model are starting to bear fruit. We believe the shorter loan durations are starting to have an impact, resulting in a faster run-off of the existing loan book while BNPL volumes continue to grow. Management is still guiding for a profitable FY26.</p><h3 class="bm-h3">Negative TPV revisions</h3><p>We still believe Qliro is in continuous growth. However, management highlights that TPV growth will not accelerate as it has before. Therefore, we lower our TPV estimates for '26e, '27e and '28e to 34%, 29% and 27% y-o-y from 40%, 35% and 30%, resulting in a decrease in net income to SEK 11.4m, 19.2m and 39m (after non-controlling interest) respectively. Our main reason for the negative revisions in net income comes from the slower TPV growth in our forecast years, as Qliro is still in a break-even phase.</p><h3 class="bm-h3">Merchant base reaches 812 (120% y-o-y)</h3><p>We remain positive about Qliro improving its BNPL penetration and credit quality, driven by improved underwriting. As Qliro now has a total merchant base of 812 (120% y-o-y), we still expect larger volumes to materialise as future earnings. We also note that total costs are beginning to level off, suggesting that investments in the new platform, including Gen Checkout 4, are starting to scale without requiring a corresponding increase in the cost base.</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-24 Cavotec - Low-margin legacy orders weigh on Q2 Cavotec Analys
2026-07-24 Cavotec - P&M order momentum sustained Cavotec Analys
2026-07-22 Inission - Strong trend to continue Inission Analys
2026-07-22 SinterCast - Q2 still tough, but we see tailwinds... SinterCast Analys
2026-07-22 Medicover - No symptoms of surprise in Q2 Medicover Analys
2026-07-22 Ework Group - Cautious optimism Ework Group Analys
2026-07-22 Donkey Republic - Helsinki deal offers further de... Donkey Repu.. Analys
2026-07-22 Medicover - In line report, reiterated targets Medicover Analys
2026-07-21 Embellence Group - Broad progress in the DTC stra... Embellence .. Analys
2026-07-21 Eltel - Earnings improve, but less than we hoped Eltel Analys
2026-07-21 CTT Systems - Getting closer to lift-off CTT Systems Analys
2026-07-21 CTT Systems - Better Q2 and OK FY'26 guidance on ... CTT Systems Analys
2026-07-21 Ework Group - Order intake turns the corner Ework Group Analys
2026-07-21 Embellence Group - Sales miss, margins resilient Embellence .. Analys
2026-07-20 Studsvik - DRPS turns, Scandpower awaits H2 Studsvik Analys
2026-07-20 Qliro - NCI miss, but TPV growth still healthy Qliro Analys
2026-07-20 Ferronordic - Positioning itself for a strong H2 Ferronordic Analys
2026-07-19 Prevas - Organic recovery delayed further Prevas Analys
2026-07-19 Ovzon - Ramping costs now for bigger wins later Ovzon Analys
2026-07-19 Alligo - Finland again ahead of plan in a solid Q2 Alligo Analys